SGO: New Option for Recurrent Ovarian Cancer? (CME/CE)

posted on Mar 19 by MedPage Today OB/Gyn in the Uncategorized category SAN FRANCISCO (MedPage Today) -- Women with recurrent or relapsed, platinum-sensitive ovarian cancer had a significantly lower risk of subsequent recurrence and less toxicity when treated with carboplatin and pegylated liposomal doxorubicin (PLD, Doxil) than with standard therapy, data from a large European study showed.